Properties of phenyl valerate esterase activities from chicken serum are comparable with soluble esterases of peripheral nerves in relation with organophosphorus compounds inhibition

Toxicology Letters

Volumn 142, Issue 1-2, 2003, Pages 1-10

  García Pérez, Adolfo G ^a   Barril, José ^a   Estévez, Jorge ^a   Vilanova, Eugenio ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Kinetics inhibition; Mipafox; Organophosphorus compound; Paraoxon; Serum; Serum carboxylesterases

Indexed keywords

BIOLOGICAL MARKER; ESTERASE; MIPAFOX; NEUROTOXIC ESTERASE; ORGANOPHOSPHORUS COMPOUND; PARAOXON; PHENYLVALERATE ESTERASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME KINETICS; ENZYME PHOSPHORYLATION; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; SERUM;

ANIMALIA; GALLUS GALLUS;

EID: 0037473419     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00469-1     Document Type: Article

References (14)

1. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates. Interactions of Esterases with Esters of Organophosphorus and Carbarmic Acids. 1972;North-Holland, Amsterdam.
2. Barril J., Estevez J., Escudero M.A., Cespedes M.V., Niguez N., Sogorb M.A., Monroy A., Vilanova E. Peripheral nerve soluble esterases are spontaneously reactivated after inhibition by paraoxon: implications for a new definition of neuropathy target esterase. Chem. Biol. Interact. 119-120:1999;541-550.
3. Carrington C.D., Abou-Donia M.B. Paraoxon reversible inhibits neurotoxic esterase. Toxicol. Appl. Pharmacol. 79:1985;175-178.
4. Escudero M.A., Sogorb M.A., Vilanova E. An automatable microassay for phenyl valerate esterase activities sensitive to organophosphorus compounds. Toxicol. Lett. 89:1996;241-247.
5. Estévez J., García-Pérez A.G., Pellín M.C., Monroy-Noyola A., Garis M.C., Benabent M., Vilanova E., Barril J. High and permanent inhibition of peripheral nerve soluble esterases by mipafox and S9B, a selective NTE inhibitor, suggest their potential role as neuropathy targets. Neurotoxicology. 21:(4):2000;635.
6. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem. J. 114:1969;711-717.
7. Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphate for delayed neurotoxicity potential. Arch. Toxicol. 37:1977;113-115.
8. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical and toxicological applications. Rev. Biochem. Toxicol. 4:1982;141-212.
9. Lotti M., Johnson M.K. Neurotoxicity of organophosphorus pestides: predictions can be based on in vitro studies with hen and human enzymes. Arch. Toxicol. 41:1978;215-221.
10. Moretto A., Jokanovid M., Lotti M. The relevance of inhibitor-substrate interactions when measuring neuropathy target esterase inhibition. Arch. Toxicol. 73:(12):2000;655-660.
11. Sogorb M.A., Pla A., Vilanova E. Las esterasas que hidrolizan compuestos organofosforados: un mecanismo eficaz de destoxificación. Rev. Toxicol. 13:1996;43-48.
12. Tormo N., Gimeno J.R., Sogorb M.A., Diaz-Alejo N., Vilanova E. Soluble and particulate organophosphorus neuropathy target esterase in brain and sciatic nerve of the hen, cat, rat, and chick. J. Neurochem. 61:1993;2164-2168.
13. Vilanova E., Barril J., Carrera V., Pellin M.C. Soluble and particulate forms of the organophosphorus neuropathy target esterase in hen sciatic nerve. J. Neurochem. 55:1990;1258-1265.
14. Vilanova E., Escudero M.A., Barril J. NTE soluble isoforms: new perspectives for targets of neuropathy inducers and promoters. Chem. Biol. Interact. 119-120:1999;525-540.